Artelo biosciences, inc. (ARTL)
Income statement / TTM
Feb'20Nov'19Aug'19May'19Feb'19Nov'18Aug'18May'18Feb'18Nov'17Aug'17May'17Feb'17Nov'16Aug'16May'16Feb'16Nov'15Aug'15May'15Feb'15Nov'14May'14Feb'14
Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

Operating Expenses Abstract
General and administrative

1,532

1,149

952

902

604

577

508

359

274

247

110

23

4

0

0

0

0

0

-

-

-

-

0

0

Professional fees

1,269

1,263

1,164

852

734

645

585

491

331

220

121

98

26

23

28

28

26

27

14

15

19

0

0

0

Research and Development Expense

1,799

1,574

1,091

1,190

1,243

1,400

1,249

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating Expenses

4,601

3,989

3,209

2,946

2,582

2,623

2,343

1,768

1,286

500

232

121

30

23

29

29

27

28

15

18

22

0

0

0

Operating Income (Loss)

-4,601

-3,989

-3,209

-2,946

-2,582

-2,623

-2,343

-1,768

-1,286

-500

-232

-121

-30

-23

-29

-29

-27

-28

-15

-18

-22

0

0

0

Other Expense, Nonoperating [Abstract]
Total other expense

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Represents the change in fair value for the period of warrant derivative liability.

926

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Total other income

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Income Tax Expense (Benefit)

-

-

-

0

-

-

-

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Net Income (Loss) Attributable to Parent

-3,866

-2,921

-2,172

-2,016

-2,249

-2,623

-2,343

-1,769

-1,287

-502

-234

-123

-31

-23

-29

-29

-27

-28

-15

-18

-22

0

0

0

Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax

26

13

2

1

-9

-7

-12

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency translation adjustments

26

13

2

1

-9

-7

-12

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total comprehensive loss

-3,840

-2,907

-2,169

-2,015

-2,259

-2,630

-2,356

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Earnings Per Share, Basic

-0.40

-0.39

-0.29

-0.17

-0.22

-0.32

-

-0.36

-0.07

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Earnings Per Share, Diluted

-0.40

-0.40

-0.34

-0.40

-0.40

-0.32

-

-0.36

-0.07

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted Average Number of Shares Outstanding, Basic

3,425

3,361

2,958

2,058

1,917

1,754

-

1,592

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted Average Number of Shares Outstanding, Diluted

3,425

3,379

2,749

2,267

1,917

1,754

-

1,592

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and Diluted Loss per Common Share (in dollars per share)

-

-

-

-

-

-

-

-

-

-0.02

-0.02

-0.01

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

-0.07

Basic and Diluted Weighted Average Common Shares Outstanding (in shares)

-

-

-

-

-

-

-

-

11,677

11,345

10,840

8,809

7,640

7,640

7,640

7,640

7,640

7,640

7,311

6,314

6,000

6,000

6,000

99